ストックスクリーナーアプリを入手
0.418
1.95%
0.008
アフターアワーズ：
.42
0.002
+0.48%
前日終値:
$0.41
開ける：
$0.41
24時間の取引高:
147.82K
Relative Volume:
0.19
時価総額：
$21.47M
収益：
$110.97M
当期純損益:
$-33.18M
株価収益率:
-0.6358
EPS:
-0.6574
ネットキャッシュフロー:
$-11.80M
1週間 パフォーマンス:
+0.31%
1か月 パフォーマンス:
-2.06%
6か月 パフォーマンス:
-88.70%
1年 パフォーマンス:
-83.21%
1日の値動き範囲:
$0.41
$0.4297
1週間の範囲:
$0.406
$0.4385
52週間の値動き範囲:
$0.40
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.418 | 21.06M | 110.97M | -33.18M | -11.80M | -0.6574 |
TMO
Thermo Fisher Scientific Inc
|
559.53 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.20 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
137.89 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
258.03 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-17 | 開始されました | Craig Hallum | Buy |
| 2024-10-31 | 開始されました | Lake Street | Buy |
| 2023-05-31 | 開始されました | TD Cowen | Outperform |
| 2022-07-18 | 再開されました | Oppenheimer | Outperform |
Mdxhealth Sa (MDXH) 最新ニュース
MDXH|MDxHealth SA|Price:0.410|Chg%:-0.012 - TradingKey
MDxHealth SA (MDXH) Cash Flow - TradingKey
MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MDXH Faces Nasdaq Compliance Challenge with Market Value Below $35M - GuruFocus
MDxHealth Faces New Nasdaq Warning Over Market Value Shortfall - TipRanks
Mdxhealth (NASDAQ: MDXH) warned on US$35M Nasdaq market value rule - Stock Titan
mdxhealth Receives Nasdaq Notice of Minimum Market Value Deficiency - Quiver Quantitative
Mdxhealth Has Until Jan. 19 to Regain Compliance or May Face Delisting - Stock Titan
MDxHealth SA (MDXH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MDxHealth SA (MDXH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MDxHealth SA (MDXH) Institutional Confidence - TradingKey
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
mdxhealth flags Nasdaq notice over US$35 million market value deficiency - Bitget
MDXH|MDxHealth SA|Price:0.411|Chg%:-0.011 - TradingKey
MDXH|MDxHealth SA|Price:0.422|Chg%:-0.015 - TradingKey
Brendan Oconnell Net Worth (2026) - GuruFocus
AWM amendment: no MDxHealth holdings reported (MDXH) - Stock Titan
MDxHealth SA explores US growth opportunities as diagnostics demand evolves - Ad-hoc-news.de
Price to sales forward of MDxHealth SA – NASDAQ:MDXH - TradingView
Enterprise value to EBITDA forward of MDxHealth SA – NASDAQ:MDXH - TradingView
Price to book forward of MDxHealth SA – NASDAQ:MDXH - TradingView
Enterprise value to revenue forward of MDxHealth SA – NASDAQ:MDXH - TradingView
Mdxhealth receives NASDAQ non-compliance notice after $1 bid price breach - MSN
Mdxhealth Faces Nasdaq Compliance Deadline After Minimum Bid Price Breach - TipRanks
Nasdaq warns mdxhealth (NASDAQ: MDXH) on $1 bid rule, eyes reverse split - Stock Titan
Mdxhealth receives Nasdaq minimum bid price deficiency notice - Investing.com
MDxHealth Gets Nasdaq Non-Compliance Notice - marketscreener.com
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Manila Times
Mdxhealth receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com Canada
Mdxhealth gets 180 days to fix Nasdaq bid-price issue - Stock Titan
MDxHealth Study Backs Prostate Cancer Test - Orange County Business Journal
MDxHealth SA(NasdaqCM: MDXH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Mdxhealth study published in European Urology Oncology - Investing.com
Mdxhealth study published in European Urology Oncology By Investing.com - Investing.com Nigeria
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial - The Manila Times
Mdxhealth study finds 92% six-year freedom from failure - Stock Titan
MDxHealth SA(NasdaqCM: MDXH) added to Russell 3000E Value Benchmark - marketscreener.com
MDxHealth S.A. Actuals & Estimates (NASDAQ:MDXH) - TradingView
MDxHealth S.A. Actuals & Estimates (SWB:O6C1) - TradingView
MDxHealth SA (MDXH) Valuation: PE, PB & Fair Value Analysis - TradingKey
MDXH Forecast — Price Target — Prediction for 2027 - TradingView
MDXH PE Ratio & Valuation, Is MDXH Overvalued - Intellectia AI
MDxHealth StockThursday technical snapshot around key support - AD HOC NEWS
MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDxHealth (MDXH) Hovers Near Key Support Level After Marginal DeclineWyckoff Upthrust - newsline.com
· Analyst Forecast - MLQ.ai
MDxHealth (MDXH) Slips 5.7% as Shares Test Key Support at $0.54Ease of Movement - newsline.com
MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant - Stock Titan
MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options - Stock Titan
Mdxhealth Sa (MDXH) 財務データ
収益
当期純利益
現金流量
EPS
1.75%
2.38%
大文字化:
|
ボリューム (24 時間):